$GILD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GILEAD SCIENCES INC. Get notifications about new insider transactions in GILEAD SCIENCES INC for free.
Page: < prev 1 ... 39 40 41 42 43 44 45 46 46 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | SHULTZ GEORGE P | Director | Sell | S | 38.57 | 5,600 | 215,992 | 275,000 | 280.6 K to 275 K (-2.00 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | SHULTZ GEORGE P | Director | Sell | S | 38.56 | 4,900 | 188,944 | 280,600 | 285.5 K to 280.6 K (-1.72 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | SHULTZ GEORGE P | Director | Sell | S | 38.55 | 2,500 | 96,375 | 285,500 | 288 K to 285.5 K (-0.87 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | SHULTZ GEORGE P | Director | Buy | M | 4.75 | 8,000 | 38,000 | 288,000 | 280 K to 288 K (+2.86 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | SHULTZ GEORGE P | Director | Buy | M | 4.00 | 200,000 | 800,000 | 280,000 | 80 K to 280 K (+250.00 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Option Exercise | M | 7.30 | 50,000 | 364,845 | 93,896 | |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Option Exercise | M | 2.86 | 19,200 | 54,900 | 0 | |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 39.11 | 1,000 | 39,110 | 36,960 | 38 K to 37 K (-2.63 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 39.10 | 400 | 15,640 | 37,960 | 38.4 K to 38 K (-1.04 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 39.07 | 2,400 | 93,768 | 38,360 | 40.8 K to 38.4 K (-5.89 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 39.06 | 400 | 15,624 | 40,760 | 41.2 K to 40.8 K (-0.97 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 39.05 | 800 | 31,240 | 41,160 | 42 K to 41.2 K (-1.91 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 39.04 | 1,000 | 39,040 | 41,960 | 43 K to 42 K (-2.33 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 39.03 | 400 | 15,612 | 42,960 | 43.4 K to 43 K (-0.92 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 39.02 | 1,000 | 39,020 | 43,360 | 44.4 K to 43.4 K (-2.25 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 39.00 | 11,800 | 460,200 | 44,360 | 56.2 K to 44.4 K (-21.01 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 39.00 | 10,000 | 390,000 | 56,160 | 66.2 K to 56.2 K (-15.11 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 38.72 | 3,000 | 116,160 | 66,160 | 69.2 K to 66.2 K (-4.34 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 38.69 | 10,000 | 386,900 | 69,160 | 79.2 K to 69.2 K (-12.63 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 38.66 | 17,000 | 657,220 | 79,160 | 96.2 K to 79.2 K (-17.68 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 38.60 | 10,000 | 386,000 | 96,160 | 106.2 K to 96.2 K (-9.42 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Buy | M | 2.86 | 19,200 | 54,900 | 106,160 | 87 K to 106.2 K (+22.08 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Buy | M | 7.30 | 50,000 | 364,845 | 86,960 | 37 K to 87 K (+135.28 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 4.09 | 120,000 | 491,256 | 66,720 | |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 39.05 | 10,000 | 390,500 | 682,858 | 692.9 K to 682.9 K (-1.44 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 39.00 | 30,000 | 1,170,000 | 692,858 | 722.9 K to 692.9 K (-4.15 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 38.85 | 10,000 | 388,500 | 722,858 | 732.9 K to 722.9 K (-1.36 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 38.84 | 10,000 | 388,400 | 732,858 | 742.9 K to 732.9 K (-1.35 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 38.80 | 20,000 | 776,000 | 742,858 | 762.9 K to 742.9 K (-2.62 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 38.77 | 10,000 | 387,700 | 762,858 | 772.9 K to 762.9 K (-1.29 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 38.75 | 10,000 | 387,500 | 772,858 | 782.9 K to 772.9 K (-1.28 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 38.70 | 10,000 | 387,000 | 782,858 | 792.9 K to 782.9 K (-1.26 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 38.62 | 10,000 | 386,200 | 792,858 | 802.9 K to 792.9 K (-1.25 %) |
| May 06 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 4.09 | 120,000 | 491,256 | 802,858 | 682.9 K to 802.9 K (+17.57 %) |
| May 05 2005 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | M | 26.73 | 30,000 | 801,900 | 30,000 | |
| May 05 2005 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 38.72 | 3,000 | 116,160 | 0 | 3 K to 0 (-100.00 %) |
| May 05 2005 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 38.69 | 10,000 | 386,900 | 3,000 | 13 K to 3 K (-76.92 %) |
| May 05 2005 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 38.66 | 17,000 | 657,220 | 13,000 | 30 K to 13 K (-56.67 %) |
| May 05 2005 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Buy | M | 26.73 | 30,000 | 801,900 | 30,000 | 0 to 30 K |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Option Exercise | M | 7.30 | 13,704 | 99,997 | 0 | |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Option Exercise | M | 3.30 | 15,996 | 52,737 | 0 | |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Option Exercise | M | 7.08 | 200 | 1,416 | 1,800 | |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Option Exercise | M | 7.08 | 28,000 | 198,190 | 0 | |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 37.50 | 8,500 | 318,750 | 9,032 | 17.5 K to 9 K (-48.48 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 37.45 | 2,000 | 74,900 | 17,532 | 19.5 K to 17.5 K (-10.24 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 37.44 | 9,700 | 363,168 | 19,532 | 29.2 K to 19.5 K (-33.18 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 37.43 | 1,800 | 67,374 | 29,232 | 31 K to 29.2 K (-5.80 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 37.42 | 4,400 | 164,648 | 31,032 | 35.4 K to 31 K (-12.42 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 37.41 | 1,400 | 52,374 | 35,432 | 36.8 K to 35.4 K (-3.80 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 37.40 | 200 | 7,480 | 36,832 | 37 K to 36.8 K (-0.54 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 37.49 | 100 | 3,749 | 37,032 | 37.1 K to 37 K (-0.27 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 37.48 | 100 | 3,748 | 37,132 | 37.2 K to 37.1 K (-0.27 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 37.35 | 4,704 | 175,694 | 37,232 | 41.9 K to 37.2 K (-11.22 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 37.34 | 3,000 | 112,020 | 41,936 | 44.9 K to 41.9 K (-6.68 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 37.33 | 4,000 | 149,320 | 44,936 | 48.9 K to 44.9 K (-8.17 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 37.32 | 2,000 | 74,640 | 48,936 | 50.9 K to 48.9 K (-3.93 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 37.38 | 900 | 33,642 | 50,936 | 51.8 K to 50.9 K (-1.74 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 37.39 | 1,100 | 41,129 | 51,836 | 52.9 K to 51.8 K (-2.08 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 37.40 | 6,100 | 228,140 | 52,936 | 59 K to 52.9 K (-10.33 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 37.37 | 2,600 | 97,162 | 59,036 | 61.6 K to 59 K (-4.22 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 37.36 | 2,500 | 93,400 | 61,636 | 64.1 K to 61.6 K (-3.90 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 37.35 | 2,796 | 104,431 | 64,136 | 66.9 K to 64.1 K (-4.18 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Buy | M | 7.08 | 28,000 | 198,190 | 66,932 | 38.9 K to 66.9 K (+71.92 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Buy | M | 7.08 | 200 | 1,416 | 38,932 | 38.7 K to 38.9 K (+0.52 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Buy | M | 7.30 | 13,704 | 99,997 | 38,732 | 25 K to 38.7 K (+54.75 %) |
| May 04 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Buy | M | 3.30 | 15,996 | 52,737 | 25,028 | 9 K to 25 K (+177.10 %) |
| May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 11.76 | 30,000 | 352,737 | 107,144 | |
| May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 36.22 | 13,700 | 496,214 | 92,302 | 106 K to 92.3 K (-12.92 %) |
| May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 36.23 | 800 | 28,984 | 106,002 | 106.8 K to 106 K (-0.75 %) |
| May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 36.24 | 500 | 18,120 | 106,802 | 107.3 K to 106.8 K (-0.47 %) |
| May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 36.25 | 200 | 7,250 | 107,302 | 107.5 K to 107.3 K (-0.19 %) |
| May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 36.26 | 2,600 | 94,276 | 107,502 | 110.1 K to 107.5 K (-2.36 %) |
| May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 36.27 | 600 | 21,762 | 110,102 | 110.7 K to 110.1 K (-0.54 %) |
| May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 36.28 | 500 | 18,140 | 110,702 | 111.2 K to 110.7 K (-0.45 %) |
| May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 36.29 | 1,300 | 47,177 | 111,202 | 112.5 K to 111.2 K (-1.16 %) |
| May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 36.30 | 1,000 | 36,300 | 112,502 | 113.5 K to 112.5 K (-0.88 %) |
| May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 36.31 | 8,800 | 319,528 | 113,502 | 122.3 K to 113.5 K (-7.20 %) |
| May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 11.76 | 30,000 | 352,737 | 122,302 | 92.3 K to 122.3 K (+32.50 %) |
| Mar 08 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Option Exercise | M | 4.00 | 40,000 | 160,000 | 20,000 | |
| Mar 08 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 35.10 | 4,000 | 140,390 | 15,000 | 19 K to 15 K (-21.05 %) |
| Mar 08 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 35.02 | 2,000 | 70,040 | 19,000 | 21 K to 19 K (-9.52 %) |
| Mar 08 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 35.05 | 3,000 | 105,150 | 21,000 | 24 K to 21 K (-12.50 %) |
| Mar 08 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 35.23 | 2,000 | 70,460 | 24,000 | 26 K to 24 K (-7.69 %) |
| Mar 08 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 35.29 | 2,000 | 70,580 | 26,000 | 28 K to 26 K (-7.14 %) |
| Mar 08 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 35.60 | 2,000 | 71,200 | 28,000 | 30 K to 28 K (-6.67 %) |
| Mar 08 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Buy | M | 4.00 | 20,000 | 80,000 | 30,000 | 10 K to 30 K (+200.00 %) |
| Feb 28 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 11.76 | 20,000 | 235,158 | 137,144 | |
| Feb 28 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 35.29 | 7,500 | 264,675 | 92,302 | 99.8 K to 92.3 K (-7.51 %) |
| Feb 28 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 35.28 | 12,500 | 441,000 | 99,802 | 112.3 K to 99.8 K (-11.13 %) |
| Feb 28 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 11.76 | 20,000 | 235,158 | 112,302 | 92.3 K to 112.3 K (+21.67 %) |
| Feb 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 4.09 | 35,000 | 143,283 | 186,720 | |
| Feb 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 35.40 | 2,625 | 92,925 | 682,858 | 685.5 K to 682.9 K (-0.38 %) |
| Feb 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 34.95 | 7,375 | 257,756 | 685,483 | 692.9 K to 685.5 K (-1.06 %) |
| Feb 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 34.75 | 5,000 | 173,750 | 692,858 | 697.9 K to 692.9 K (-0.72 %) |
| Feb 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 34.71 | 10,000 | 347,100 | 697,858 | 707.9 K to 697.9 K (-1.41 %) |
| Feb 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 34.65 | 10,000 | 346,500 | 707,858 | 717.9 K to 707.9 K (-1.39 %) |
| Feb 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 4.09 | 35,000 | 143,283 | 717,858 | 682.9 K to 717.9 K (+5.13 %) |
| Feb 16 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Option Exercise | M | 7.30 | 166,296 | 1,213,445 | 0 | |
| Feb 16 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 33.18 | 3,200 | 106,176 | 800 | 4 K to 800 (-80.00 %) |
| Feb 16 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 33.12 | 3,013 | 99,791 | 800 | 3.8 K to 800 (-79.02 %) |
| Feb 16 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 33.15 | 187 | 6,199 | 3,813 | 4 K to 3.8 K (-4.67 %) |
| Feb 16 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 33.29 | 20,000 | 665,800 | 448,182 | 468.2 K to 448.2 K (-4.27 %) |
| Feb 16 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 33.17 | 46,296 | 1,535,638 | 468,182 | 514.5 K to 468.2 K (-9.00 %) |
| Feb 16 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 33.16 | 25,000 | 829,105 | 514,478 | 539.5 K to 514.5 K (-4.63 %) |
| Feb 16 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 33.10 | 75,000 | 2,482,500 | 539,478 | 614.5 K to 539.5 K (-12.21 %) |
| Feb 16 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Buy | M | 7.30 | 166,296 | 1,213,445 | 614,478 | 448.2 K to 614.5 K (+37.10 %) |
| Feb 15 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Gift | G | 0.00 | 2,078 | 0 | 682,858 | 684.9 K to 682.9 K (-0.30 %) |
| Feb 15 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Gift | G | 0.00 | 2,078 | 0 | 684,936 | 687 K to 684.9 K (-0.30 %) |
| Feb 10 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 4.09 | 85,000 | 347,973 | 221,720 | |
| Feb 10 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 32.24 | 10,000 | 322,400 | 687,014 | 697 K to 687 K (-1.43 %) |
| Feb 10 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 32.27 | 10,000 | 322,700 | 697,014 | 707 K to 697 K (-1.41 %) |
| Feb 10 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 32.20 | 10,000 | 322,000 | 707,014 | 717 K to 707 K (-1.39 %) |
| Feb 10 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 32.12 | 10,000 | 321,200 | 717,014 | 727 K to 717 K (-1.38 %) |
| Feb 10 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 32.10 | 7,500 | 240,750 | 727,014 | 734.5 K to 727 K (-1.02 %) |
| Feb 10 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 32.01 | 12,500 | 400,125 | 734,514 | 747 K to 734.5 K (-1.67 %) |
| Feb 10 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 31.50 | 10,000 | 315,000 | 747,014 | 757 K to 747 K (-1.32 %) |
| Feb 10 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 31.75 | 15,000 | 476,250 | 757,014 | 772 K to 757 K (-1.94 %) |
| Feb 10 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 4.09 | 85,000 | 347,973 | 772,014 | 687 K to 772 K (+12.37 %) |
| Jan 28 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Option Exercise | A | 32.02 | 71,877 | 2,301,502 | 71,877 | |
| Jan 28 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Option Exercise | A | 32.02 | 3,123 | 99,998 | 3,123 | |
| Jan 28 2005 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | A | 32.02 | 121,877 | 3,902,502 | 121,877 | |
| Jan 28 2005 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | A | 32.02 | 3,123 | 99,998 | 3,123 | |
| Jan 28 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | A | 32.02 | 171,877 | 5,503,502 | 171,877 | |
| Jan 28 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | A | 32.02 | 3,123 | 99,998 | 3,123 | |
| Jan 28 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Option Exercise | A | 32.02 | 171,877 | 5,503,502 | 171,877 | |
| Jan 28 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Option Exercise | A | 32.02 | 3,123 | 99,998 | 3,123 | |
| Jan 28 2005 | GILD | GILEAD SCIENCES IN ... | CARACCIOLO ANTHONY | SVP | Option Exercise | A | 32.02 | 81,877 | 2,621,702 | 81,877 | |
| Jan 28 2005 | GILD | GILEAD SCIENCES IN ... | CARACCIOLO ANTHONY | SVP | Option Exercise | A | 32.02 | 3,123 | 99,998 | 3,123 | |
| Jan 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | A | 32.02 | 421,877 | 13,508,502 | 421,877 | |
| Jan 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | A | 32.02 | 3,123 | 99,998 | 3,123 | |
| Jan 28 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Option Exercise | A | 32.02 | 81,877 | 2,621,702 | 81,877 | |
| Jan 28 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Option Exercise | A | 32.02 | 3,123 | 99,998 | 3,123 | |
| Dec 30 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 3.27 | 20,000 | 65,314 | 29,640 | |
| Dec 30 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 3.27 | 20,000 | 65,314 | 687,014 | 667 K to 687 K (+3.00 %) |
| Dec 22 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Option Exercise | M | 3.27 | 30,000 | 97,971 | 50,000 | |
| Dec 22 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Buy | M | 3.27 | 30,000 | 97,971 | 36,960 | 7 K to 37 K (+431.03 %) |
| Dec 16 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Option Exercise | M | 2.86 | 6,600 | 18,872 | 0 | |
| Dec 16 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Option Exercise | M | 3.30 | 1,000 | 3,297 | 15,996 | |
| Dec 16 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Buy | M | 2.86 | 6,600 | 18,872 | 9,032 | 2.4 K to 9 K (+271.38 %) |
| Dec 16 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Buy | M | 3.30 | 1,000 | 3,297 | 2,432 | 1.4 K to 2.4 K (+69.83 %) |
| Dec 30 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 7.30 | 4,000 | 29,188 | 4,000 | |
| Dec 30 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 7.30 | 4,000 | 29,188 | 92,302 | 88.3 K to 92.3 K (+4.53 %) |
| Dec 10 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Option Exercise | M | 4.78 | 8,000 | 38,250 | 108,000 | |
| Dec 10 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 35.43 | 8,000 | 283,440 | 8,000 | 16 K to 8 K (-50.00 %) |
| Dec 10 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Grant | A | 4.78 | 8,000 | 38,250 | 16,000 | 8 K to 16 K (+100.00 %) |
| Dec 01 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Option Exercise | M | 3.27 | 26,632 | 86,972 | 0 | |
| Dec 01 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Option Exercise | M | 2.86 | 6,000 | 17,156 | 28,968 | |
| Dec 01 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Buy | M | 3.27 | 26,632 | 86,972 | 448,182 | 421.6 K to 448.2 K (+6.32 %) |
| Dec 01 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Buy | M | 2.86 | 6,000 | 17,156 | 421,550 | 415.6 K to 421.6 K (+1.44 %) |
| Nov 23 2004 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | M | 31.40 | 42,000 | 1,318,800 | 0 |